YU183988A - Process for preparing dispersion pills of dihydroergotoxine - Google Patents

Process for preparing dispersion pills of dihydroergotoxine

Info

Publication number
YU183988A
YU183988A YU01839/88A YU183988A YU183988A YU 183988 A YU183988 A YU 183988A YU 01839/88 A YU01839/88 A YU 01839/88A YU 183988 A YU183988 A YU 183988A YU 183988 A YU183988 A YU 183988A
Authority
YU
Yugoslavia
Prior art keywords
dihydroergotoxine
pills
preparing dispersion
dispersion
preparing
Prior art date
Application number
YU01839/88A
Other languages
English (en)
Inventor
J Miliovac
M Kovacic
Z Kopitar
J U Smerkolj
A Lenardic
M Zorz
B Kofler
A V Mozina
V Mikolic
M Lampert
B Meden
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Priority to YU01839/88A priority Critical patent/YU183988A/xx
Priority to EP89117650A priority patent/EP0361354A1/en
Priority to CA000613266A priority patent/CA1335573C/en
Priority to US07/412,740 priority patent/US5047247A/en
Priority to JP1252538A priority patent/JPH02129124A/ja
Priority to KR1019890014160A priority patent/KR900004326A/ko
Publication of YU183988A publication Critical patent/YU183988A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU01839/88A 1988-09-30 1988-09-30 Process for preparing dispersion pills of dihydroergotoxine YU183988A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
YU01839/88A YU183988A (en) 1988-09-30 1988-09-30 Process for preparing dispersion pills of dihydroergotoxine
EP89117650A EP0361354A1 (en) 1988-09-30 1989-09-25 Dispersable dihydroergotoxin tablets
CA000613266A CA1335573C (en) 1988-09-30 1989-09-26 Dispersible tablets of dihydroergotoxine and of acid addition salts thereof
US07/412,740 US5047247A (en) 1988-09-30 1989-09-26 Dispersible tablets of dihydroergotoxine methanesulfonate and of acid addition salts thereof
JP1252538A JPH02129124A (ja) 1988-09-30 1989-09-29 ジヒドロエルゴトキシン又はその酸付加塩の分散性錠剤及びその製造方法
KR1019890014160A KR900004326A (ko) 1988-09-30 1989-09-30 디히드로에르고톡신 및 그의 산 부가염의 분산성 정제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU01839/88A YU183988A (en) 1988-09-30 1988-09-30 Process for preparing dispersion pills of dihydroergotoxine

Publications (1)

Publication Number Publication Date
YU183988A true YU183988A (en) 1990-08-31

Family

ID=25555799

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01839/88A YU183988A (en) 1988-09-30 1988-09-30 Process for preparing dispersion pills of dihydroergotoxine

Country Status (6)

Country Link
US (1) US5047247A (xx)
EP (1) EP0361354A1 (xx)
JP (1) JPH02129124A (xx)
KR (1) KR900004326A (xx)
CA (1) CA1335573C (xx)
YU (1) YU183988A (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
US5523289A (en) * 1991-04-15 1996-06-04 Abbott Laboratories Pharmaceutical composition
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
GB9220667D0 (en) † 1992-09-30 1992-11-11 Unilever Plc Improvements in or relating to dioic acids
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
GB2392446A (en) * 2002-09-02 2004-03-03 Reckitt Benckiser Nv Resin comprising water-soluble polymer and water-soluble filler
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound
WO2008104996A2 (en) * 2007-02-28 2008-09-04 Jubilant Organosys Limited Water dispersible pharmaceutical formulation and process for preparing the same
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EP3753921A1 (en) 2014-07-02 2020-12-23 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5468M (xx) * 1966-06-24 1967-10-16
US4122177A (en) * 1976-09-02 1978-10-24 Sandoz Ltd. Method of treating oligospermia and asthenospermia
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system

Also Published As

Publication number Publication date
US5047247A (en) 1991-09-10
KR900004326A (ko) 1990-04-12
JPH02129124A (ja) 1990-05-17
CA1335573C (en) 1995-05-16
EP0361354A1 (en) 1990-04-04

Similar Documents

Publication Publication Date Title
HUT51272A (en) Process for producing thiadiazin derivatives and pharmaceutical composirions containing them
YU183988A (en) Process for preparing dispersion pills of dihydroergotoxine
HU903281D0 (en) Process for producing 2-hydroxy-n-propyl-amines and containing them pharmaceutical preparatives
HU900041D0 (en) Process for preparation of thiazole-derivatives
HU896774D0 (en) Process for preparation of condensated-quinoline-derivatives
HU896728D0 (en) Process for preparation of mono-n-alkylated polyzamacrocyclides
GB8827389D0 (en) Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
HU896623D0 (en) Process for preparation of fluorinated-diphenyl-ethers
EG20414A (en) Process for preparing of improved capsules
EP0320301A3 (en) Process for preparation of hydrocarbons
GB8803404D0 (en) Process for preparation of activated carbon
YU125389A (en) Process for preparing derivatives of tricyclical 3-oxo-propan-nitryl
HUT52737A (en) Process for production of silicium-nitrid containing big alpha-phase
HU900040D0 (en) Process for preparation of (pyrrolil-phenyl)-substituted-hydroxamacid-derivatives
HUT50189A (en) Process for production of n-phosphomethil-glycin
EP0308962A3 (en) Process for production of dimethylnaphthalenes
HU895128D0 (en) Process for preparation of oxazolidine- and imidazolidine-derivatives
GB8808831D0 (en) Process for preparation of alkanediols
HUT48279A (en) Process for synthese of izopolipeptides
HU896622D0 (en) Process for preparation of 3-benzyl-4-fluor-benzaldehyde
GB8806526D0 (en) Process for preparation of alkanediols
HUT51588A (en) Process for production of 3-aryl-izobuthyl-alcaloides
HU896744D0 (en) Process for preparation of intermediers
HU901260D0 (en) Process for preparation of bisphenethanolamines
HUT58743A (en) Process for producing benzo-thio-pyrano-pyrazols of pharmaceutical activity